CNS & Neurological Disorders - Drug Targets
Title: Editorial [Hot Topic:Depression (Part 1) (Guest Editors: John H. Kehne and Ronald S. Duman)]
Volume: 6 Issue: 2
Author(s): Ronald S. Duman and John H. Kehne
Affiliation:
Export Options
About this article
Cite this article as:
Duman S. Ronald and Kehne H. John, Editorial [Hot Topic:Depression (Part 1) (Guest Editors: John H. Kehne and Ronald S. Duman)], CNS & Neurological Disorders - Drug Targets 2007; 6 (2) . https://dx.doi.org/10.2174/187152707780363249
DOI https://dx.doi.org/10.2174/187152707780363249 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
Current Medicinal Chemistry Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Prediction of Potential Targets of an Emerging Zoonotic Paramyxovirus: An Integrated Bioinformatics Analysis
Current Pharmacogenomics and Personalized Medicine Methods for Evaluating Sensory, Affective and Cognitive Disorders in Neuropathic Rodents
Current Neuropharmacology Selective Neuronal Nitric Oxide Synthase Inhibitors
Current Topics in Medicinal Chemistry Neuropsychiatric Systemic Lupus Erythematosus
Current Neuropharmacology Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy
Current Topics in Medicinal Chemistry Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy Serotonin Transporter Gene Variants and Behavior: A Comprehensive Review
Current Drug Targets Two -Year Efficacy and Safety of Botulinum a Toxin Intravesical Injections in Patients Affected by Refractory Painful Bladder Syndrome
Current Drug Delivery Investigation of Antioxidant Activity and Trace Metals in Medicinal Plants in Kashmir, Pakistan
Current Analytical Chemistry Antiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills
Current Pharmaceutical Design Modulators of Voltage-Dependent Calcium Channels for the Treatment of Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Melanoma
Current Cancer Therapy Reviews F508del-CFTR Rescue: A Matter of Cell Stress Response
Current Pharmaceutical Design Autism: Pathophysiology and Promising Herbal Remedies
Current Pharmaceutical Design Anderson-Fabry Disease: A Multiorgan Disease
Current Pharmaceutical Design Fluoroquinolones: Blessings Or Curses
Current Drug Targets Imiquimod
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Current Medicinal Chemistry